SoftOx Solutions AS (OSL:SOFTX)

Market Cap	167.14M
Revenue (ttm)	7.91M
Net Income (ttm)	-50.46M
Shares Out	2.24B
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,691,280
Average Volume	47,809,086
Open	0.0640
Previous Close	0.0624
Day's Range	0.0570 - 0.0650
52-Week Range	0.0100 - 2.7800
Beta	1.38
RSI	65.37
Earnings Date	Jun 10, 2025

About SoftOx Solutions AS

SoftOx Solutions AS, together with its subsidiaries, operates as a medtech and clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. Its products include SafeDes+, a hand disinfectant for irritated, compromised, and eczematous skin; and EffectDesH, a surface disinfectant, which has a killing/inactivation effect on bacteria, viruses, yeast, fungi, mycobacterium, and spores. The company also provides human wound and infection treatment products comprising SoftOx Wound Irrigat...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 7
• Stock Exchange: Oslo Børs
• Ticker Symbol: SOFTX

Financial Performance

In 2024, SoftOx Solutions AS's revenue was 7.91 million, an increase of 13.38% compared to the previous year's 6.98 million. Losses were -50.46 million, 27.9% more than in 2023.